跳至主要内容
临床试验/NL-OMON32620
NL-OMON32620尚未招募不适用

Generation of large-scale mature, monocyte-derived dendritic cells from adult cancer patients for the development of dendritic cell anti-cancer immunotherapy. - Production of DCs from cancer patients

Academisch Medisch Centrum0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • •histologically confirmed PC/EAC
  • •karnofsky performance status >60%
  • •patient must be eligible to undergo leukapheresis (see inclusion criteria in protocol)
  • •patient must have signed written consent

排除标准

  • •infection with hepatitis B, hepatitis C, HIV, HTLV and/or T. Pallidum
  • •severe hyperbilirubinemia, leukopenia, anaemia (see exclusioncriteria in protocol)
  • •karnofsky performance status <60%

研究者

相似试验